Soley Therapeutics raised $200 million in Series C financing to advance oncology programs and scale its platform.
- Amount
- $200M
- Stage
- Series C
- Announced
- 7 January 2026
- Lead
- Surveyor Capital
- Other investors
- HRTG Partners, RWN Management, Doug Leone Family Fund, Breyer Capital, GordonMD Global Investments® LP
- Use of funds
- Proceeds will support IND-enabling work and clinical trials for two oncology assets, non-oncology candidates, and platform scale-up.
- Checked
- Amount and date checked against the press source